Table 1.

Ingenuity pathway analysis of genes differentially expressed in SZ vs. control dlPFC gray matter.

Canonical pathway	p-value (Benjamini–Hochberg corrected)	Genes
LXR/RXR activation	3.89E − 07	AGT, APOC2, C4A/C4B, IL1RL1, S100A8, SERPINA1, TNFRSF11B
Complement system	1.15E − 05	C1QA, C1QB, C1QC, C4A/C4B
Antigen presentation pathway	1.43E − 05	HLA-DMA, HLA-DQB1, HLA-DRB3, HLA-DRB5
PD1-PD-L cancer immunotherapy pathway	5.45E − 05	HLA-DMA, HLA-DQB1, HLA-DRB3, HLA-DRB5, TNFRSF11B
T-helper cell differentiation	1.71E − 04	HLA-DMA, HLA-DQB1, HLA-DRB5, TNFRSF11B